Skip to main content
Erschienen in: International Archives of Occupational and Environmental Health 3/2005

01.04.2005 | Original Article

Functional adrenergic receptor polymorphisms and idiopathic orthostatic intolerance

verfasst von: R. Winker, A. Barth, E. Valic, R. Maier, W. Osterode, A. Pilger, H. W. Rüdiger

Erschienen in: International Archives of Occupational and Environmental Health | Ausgabe 3/2005

Einloggen, um Zugang zu erhalten

Abstract

Objectives: Idiopathic orthostatic intolerance (IOI) is a common disorder that is characterized by chronic orthostatic symptoms and substantial increases in heart rate and plasma norepinephrine concentrations that are disproportionately high while standing. Several features of the syndrome, including the tachycardia, tremulousness, and exaggerated norepinephrine have been considered potentially due to hypoactive or hyperactive states of adrenergic receptors of the sympathetic nervous system. The aim of this study was therefore to ascertain whether genotypes at eight polymorphic loci within five relevant adrenergic receptor genes (α2A, α2B, α2C, β1 and β2) influence the risk for IOI. Methods: We studied 80 young men in military service (20 patients with IOI and 60 age-matched controls). All participants underwent a tilt table test including monitoring of blood pressure, heart rate and plasma catecholamines, in the supine position and during 30 min of standing. Genotyping at the eight loci (α2ALys251, α2BDel301-303, α2CDel322-325, β1Gly49, β1Arg389, β2Arg16, β2Glu27, β2Ile164) was performed in all participants. Chi-square tests of independence were used to test for associations between IOI and genotype. In addition, an association of the polymorphisms with haemodynamic variables (heart rate, supine and upright blood pressure) was ascertained using one-way variance analysis. Results: For the β1Gly49 polymorphism we found a decrease in the risk of IOI among persons who were homozygous (odds ratio, 0.88; 95% confidence interval, 0.81–0.97). In addition, we found an association between β1Gly49 and decreased heart rate in the upright position, regardless of IOI diagnosis. There were no associations with the other studied polymorphisms and IOI. Conclusions: Our current results suggest that the β1Gly49 polymorphism is protective for IOI. This is likely one of several common genetic loci that may represent modifiers of IOI phenotypes.
Literatur
Zurück zum Zitat Bray MS, Krushkal J, Li L, Ferrell R, Kardia S, Sing CF, Turner ST, Boerwinkle E (2000) Positional genomic analysis identifies the beta(2)-adrenergic receptor gene as a susceptibility locus for human hypertension. Circulation 101:2877–2882 Bray MS, Krushkal J, Li L, Ferrell R, Kardia S, Sing CF, Turner ST, Boerwinkle E (2000) Positional genomic analysis identifies the beta(2)-adrenergic receptor gene as a susceptibility locus for human hypertension. Circulation 101:2877–2882
Zurück zum Zitat Brodde O E, Buscher R, Tellkamp R, Radke J, Dhein S, Insel P A (2001) Blunted cardiac responses to receptor activation in subjects with Thr164Ile beta(2)-adrenoceptors. Circulation 103:1048–1050 Brodde O E, Buscher R, Tellkamp R, Radke J, Dhein S, Insel P A (2001) Blunted cardiac responses to receptor activation in subjects with Thr164Ile beta(2)-adrenoceptors. Circulation 103:1048–1050
Zurück zum Zitat Dishy V, Sofowora GG, Xie HG, Kim RB, Byrne DW, Stein CM, Wood AJ (2001) The effect of common polymorphisms of the beta2-adrenergic receptor on agonist-mediated vascular desensitization. N Engl J Med 345:1030–1035 Dishy V, Sofowora GG, Xie HG, Kim RB, Byrne DW, Stein CM, Wood AJ (2001) The effect of common polymorphisms of the beta2-adrenergic receptor on agonist-mediated vascular desensitization. N Engl J Med 345:1030–1035
Zurück zum Zitat Drysdale CM, McGraw DW, Stack CB, Stephens JC, Judson RS, Nandabalan K, Arnold K, Ruano G, Liggett SB (2000) Complex promoter and coding region beta 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness. Proc Natl Acad Sci U S A 97:10483–10488 Drysdale CM, McGraw DW, Stack CB, Stephens JC, Judson RS, Nandabalan K, Arnold K, Ruano G, Liggett SB (2000) Complex promoter and coding region beta 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness. Proc Natl Acad Sci U S A 97:10483–10488
Zurück zum Zitat Farquhar W B, Taylor J A, Darling S E, Chase K P, Freeman R (2000) Abnormal baroreflex responses in patients with idiopathic orthostatic intolerance. Circulation 102:3086–3091 Farquhar W B, Taylor J A, Darling S E, Chase K P, Freeman R (2000) Abnormal baroreflex responses in patients with idiopathic orthostatic intolerance. Circulation 102:3086–3091
Zurück zum Zitat Gratze G, Fortin J, Holler A, Grasenick K, Pfurtscheller G, Wach P, Schonegger J, Kotanko P, Skrabal F (1998) A software package for non-invasive, real-time beat-to-beat monitoring of stroke volume, blood pressure, total peripheral resistance and for assessment of autonomic function. Comput Biol Med 28:121–142 Gratze G, Fortin J, Holler A, Grasenick K, Pfurtscheller G, Wach P, Schonegger J, Kotanko P, Skrabal F (1998) A software package for non-invasive, real-time beat-to-beat monitoring of stroke volume, blood pressure, total peripheral resistance and for assessment of autonomic function. Comput Biol Med 28:121–142
Zurück zum Zitat Green SA, Cole G, Jacinto M, Innis M, Liggett SB (1993) A polymorphism of the human beta 2-adrenergic receptor within the fourth transmembrane domain alters ligand binding and functional properties of the receptor. J Biol Chem 268:23116–23121 Green SA, Cole G, Jacinto M, Innis M, Liggett SB (1993) A polymorphism of the human beta 2-adrenergic receptor within the fourth transmembrane domain alters ligand binding and functional properties of the receptor. J Biol Chem 268:23116–23121
Zurück zum Zitat Green SA, Turki J, Innis M, Liggett SB (1994) Amino-terminal polymorphisms of the human beta 2-adrenergic receptor impart distinct agonist-promoted regulatory properties. Biochemistry 33:9414–9419PubMed Green SA, Turki J, Innis M, Liggett SB (1994) Amino-terminal polymorphisms of the human beta 2-adrenergic receptor impart distinct agonist-promoted regulatory properties. Biochemistry 33:9414–9419PubMed
Zurück zum Zitat Grubb BP, Kosinski DJ, Kanjwal Y (2003) Orthostatic hypotension: causes, classification, and treatment. Pacing Clin Electrophysiol 26:892–901 Grubb BP, Kosinski DJ, Kanjwal Y (2003) Orthostatic hypotension: causes, classification, and treatment. Pacing Clin Electrophysiol 26:892–901
Zurück zum Zitat Heinonen P, Jartti L, Jarvisalo MJ, Pesonen U, Kaprio JA, Ronnemaa T, Raitakari OT, Scheinin M (2002) Deletion polymorphism in the alpha2B-adrenergic receptor gene is associated with flow-mediated dilatation of the brachial artery. Clin Sci Lond 103:517–524 Heinonen P, Jartti L, Jarvisalo MJ, Pesonen U, Kaprio JA, Ronnemaa T, Raitakari OT, Scheinin M (2002) Deletion polymorphism in the alpha2B-adrenergic receptor gene is associated with flow-mediated dilatation of the brachial artery. Clin Sci Lond 103:517–524
Zurück zum Zitat Hoit BD, Suresh DP, Craft L, Walsh RA, Liggett SB (2000) Beta2-adrenergic receptor polymorphisms at amino acid 16 differentially influence agonist-stimulated blood pressure and peripheral blood flow in normal individuals. Am Heart J 139:537–542 Hoit BD, Suresh DP, Craft L, Walsh RA, Liggett SB (2000) Beta2-adrenergic receptor polymorphisms at amino acid 16 differentially influence agonist-stimulated blood pressure and peripheral blood flow in normal individuals. Am Heart J 139:537–542
Zurück zum Zitat Jacob G, Biaggioni I (1999) Idiopathic orthostatic intolerance and postural tachycardia syndromes. Am J Med Sci 317:88–101 Jacob G, Biaggioni I (1999) Idiopathic orthostatic intolerance and postural tachycardia syndromes. Am J Med Sci 317:88–101
Zurück zum Zitat January B, Seibold A, Allal C, Whaley BS, Knoll BJ, Moore RH, Dickey BF, Barber R, Clark RB (1998) Salmeterol-induced desensitization, internalization and phosphorylation of the human beta2-adrenoceptor. Br J Pharmacol 123:701–711 January B, Seibold A, Allal C, Whaley BS, Knoll BJ, Moore RH, Dickey BF, Barber R, Clark RB (1998) Salmeterol-induced desensitization, internalization and phosphorylation of the human beta2-adrenoceptor. Br J Pharmacol 123:701–711
Zurück zum Zitat Johnson JA, Zineh I, Puckett BJ, McGorray SP, Yarandi HN, Pauly DF (2003) Beta 1-adrenergic receptor polymorphisms and antihypertensive response to metoprolol. Clin Pharmacol Ther 74:44–52 Johnson JA, Zineh I, Puckett BJ, McGorray SP, Yarandi HN, Pauly DF (2003) Beta 1-adrenergic receptor polymorphisms and antihypertensive response to metoprolol. Clin Pharmacol Ther 74:44–52
Zurück zum Zitat Jordan J, Shannon JR, Jacob G, Pohar B, Robertson D (1999) Interaction of genetic predisposition and environmental factors in the pathogenesis of idiopathic orthostatic intolerance. Am J Med Sci 318:298–303 Jordan J, Shannon JR, Jacob G, Pohar B, Robertson D (1999) Interaction of genetic predisposition and environmental factors in the pathogenesis of idiopathic orthostatic intolerance. Am J Med Sci 318:298–303
Zurück zum Zitat Jordan J, Shannon JR, Diedrich A, Black BK, Robertson D (2002) Increased sympathetic activation in idiopathic orthostatic intolerance: role of systemic adrenoreceptor sensitivity. Hypertension 39:173–178 Jordan J, Shannon JR, Diedrich A, Black BK, Robertson D (2002) Increased sympathetic activation in idiopathic orthostatic intolerance: role of systemic adrenoreceptor sensitivity. Hypertension 39:173–178
Zurück zum Zitat Liggett S B, Wagoner LE, Craft LL, Hornung RW, Hoit BD, McIntosh TC, Walsh RA (1998) The Ile164 beta2-adrenergic receptor polymorphism adversely affects the outcome of congestive heart failure. J Clin Invest 102:1534–1539 Liggett S B, Wagoner LE, Craft LL, Hornung RW, Hoit BD, McIntosh TC, Walsh RA (1998) The Ile164 beta2-adrenergic receptor polymorphism adversely affects the outcome of congestive heart failure. J Clin Invest 102:1534–1539
Zurück zum Zitat Mason DA, Moore JD, Green SA, Liggett SB (1999) A gain-of-function polymorphism in a G-protein coupling domain of the human beta1-adrenergic receptor. J Biol Chem 274:12670–12674CrossRefPubMed Mason DA, Moore JD, Green SA, Liggett SB (1999) A gain-of-function polymorphism in a G-protein coupling domain of the human beta1-adrenergic receptor. J Biol Chem 274:12670–12674CrossRefPubMed
Zurück zum Zitat Mialet Perez J, Rathz DA, Petrashevskaya NN, Hahn HS, Wagoner LE, Schwartz A, Dorn GW, Liggett SB (2003) Beta 1-adrenergic receptor polymorphisms confer differential function and predisposition to heart failure. Nat Med 9:1300–1305 Mialet Perez J, Rathz DA, Petrashevskaya NN, Hahn HS, Wagoner LE, Schwartz A, Dorn GW, Liggett SB (2003) Beta 1-adrenergic receptor polymorphisms confer differential function and predisposition to heart failure. Nat Med 9:1300–1305
Zurück zum Zitat Ranade K, Jorgenson E, Sheu WH, Pei D, Hsiung CA, Chiang FT, Chen YD, Pratt R, Olshen RA, Curb D, Cox DR, Botstein D, Risch N (2002) A polymorphism in the beta1 adrenergic receptor is associated with resting heart rate. Am J Hum Genet 70:935–942 Ranade K, Jorgenson E, Sheu WH, Pei D, Hsiung CA, Chiang FT, Chen YD, Pratt R, Olshen RA, Curb D, Cox DR, Botstein D, Risch N (2002) A polymorphism in the beta1 adrenergic receptor is associated with resting heart rate. Am J Hum Genet 70:935–942
Zurück zum Zitat Rathz DA, Brown KM, Kramer LA, Liggett SB (2002) Amino acid 49 polymorphisms of the human beta1-adrenergic receptor affect agonist-promoted trafficking. J Cardiovasc Pharmacol 39:155–160 Rathz DA, Brown KM, Kramer LA, Liggett SB (2002) Amino acid 49 polymorphisms of the human beta1-adrenergic receptor affect agonist-promoted trafficking. J Cardiovasc Pharmacol 39:155–160
Zurück zum Zitat Shannon JR, Flattem NL, Jordan J, Jacob G, Black BK, Biaggioni I, Blakely RD, Robertson D (2000) Orthostatic intolerance and tachycardia associated with norepinephrine-transporter deficiency. N Engl J Med 342:541–549CrossRefPubMed Shannon JR, Flattem NL, Jordan J, Jacob G, Black BK, Biaggioni I, Blakely RD, Robertson D (2000) Orthostatic intolerance and tachycardia associated with norepinephrine-transporter deficiency. N Engl J Med 342:541–549CrossRefPubMed
Zurück zum Zitat Shibata K, Hirasawa A, Moriyama N, Kawabe K, Ogawa S, Tsujimoto G (1996) Alpha 1a-adrenoceptor polymorphism: pharmacological characterization and association with benign prostatic hypertrophy. Br J Pharmacol 118:1403–1408PubMed Shibata K, Hirasawa A, Moriyama N, Kawabe K, Ogawa S, Tsujimoto G (1996) Alpha 1a-adrenoceptor polymorphism: pharmacological characterization and association with benign prostatic hypertrophy. Br J Pharmacol 118:1403–1408PubMed
Zurück zum Zitat Small KM, Liggett SB (2001) Identification and functional characterization of alpha(2)-adrenoceptor polymorphisms. Trends Pharmacol Sci 22:471–477 Small KM, Liggett SB (2001) Identification and functional characterization of alpha(2)-adrenoceptor polymorphisms. Trends Pharmacol Sci 22:471–477
Zurück zum Zitat Small KM, Forbes SL, Brown KM, Liggett SB (2000a) An asn to lys polymorphism in the third intracellular loop of the human alpha 2A-adrenergic receptor imparts enhanced agonist-promoted Gi coupling. J Biol Chem 275:38518–38523CrossRefPubMed Small KM, Forbes SL, Brown KM, Liggett SB (2000a) An asn to lys polymorphism in the third intracellular loop of the human alpha 2A-adrenergic receptor imparts enhanced agonist-promoted Gi coupling. J Biol Chem 275:38518–38523CrossRefPubMed
Zurück zum Zitat Small KM, Forbes SL, Rahman FF, Bridges KM, Liggett SB (2000b) A four amino acid deletion polymorphism in the third intracellular loop of the human alpha 2C-adrenergic receptor confers impaired coupling to multiple effectors. J Biol Chem 275:23059–23064CrossRefPubMed Small KM, Forbes SL, Rahman FF, Bridges KM, Liggett SB (2000b) A four amino acid deletion polymorphism in the third intracellular loop of the human alpha 2C-adrenergic receptor confers impaired coupling to multiple effectors. J Biol Chem 275:23059–23064CrossRefPubMed
Zurück zum Zitat Small KM, Brown KM, Forbes SL, Liggett SB (2001) Polymorphic deletion of three intracellular acidic residues of the alpha 2B-adrenergic receptor decreases G protein-coupled receptor kinase-mediated phosphorylation and desensitization. J Biol Chem 276:4917–4922CrossRefPubMed Small KM, Brown KM, Forbes SL, Liggett SB (2001) Polymorphic deletion of three intracellular acidic residues of the alpha 2B-adrenergic receptor decreases G protein-coupled receptor kinase-mediated phosphorylation and desensitization. J Biol Chem 276:4917–4922CrossRefPubMed
Zurück zum Zitat Small KM, Rathz DA, Liggett SB (2002a) Identification of adrenergic receptor polymorphisms. Methods Enzymol 343:459–475 Small KM, Rathz DA, Liggett SB (2002a) Identification of adrenergic receptor polymorphisms. Methods Enzymol 343:459–475
Zurück zum Zitat Small KM, Wagoner LE, Levin AM, Kardia SL, Liggett SB (2002b) Synergistic polymorphisms of beta1- and alpha2C-adrenergic receptors and the risk of congestive heart failure. N Engl J Med 347:1135–1142 Small KM, Wagoner LE, Levin AM, Kardia SL, Liggett SB (2002b) Synergistic polymorphisms of beta1- and alpha2C-adrenergic receptors and the risk of congestive heart failure. N Engl J Med 347:1135–1142
Zurück zum Zitat Small KM, McGraw DW, Liggett SB (2003) Pharmacology and physiology of human adrenergic receptor polymorphisms. Annu Rev Pharmacol Toxicol 43:381–411 Small KM, McGraw DW, Liggett SB (2003) Pharmacology and physiology of human adrenergic receptor polymorphisms. Annu Rev Pharmacol Toxicol 43:381–411
Zurück zum Zitat Tschernko EM, Hofer S, Bieglmayer C, Wisser W, Haider W (1996) Early postoperative stress: video-assisted wedge resection/lobectomy vs conventional axillary thoracotomy. Chest 109:1636–1642 Tschernko EM, Hofer S, Bieglmayer C, Wisser W, Haider W (1996) Early postoperative stress: video-assisted wedge resection/lobectomy vs conventional axillary thoracotomy. Chest 109:1636–1642
Zurück zum Zitat Turki J, Lorenz JN, Green SA, Donnelly ET, Jacinto M, Liggett SB (1996) Myocardial signaling defects and impaired cardiac function of a human beta 2-adrenergic receptor polymorphism expressed in transgenic mice. Proc Natl Acad Sci U S A 93:10483–10488 Turki J, Lorenz JN, Green SA, Donnelly ET, Jacinto M, Liggett SB (1996) Myocardial signaling defects and impaired cardiac function of a human beta 2-adrenergic receptor polymorphism expressed in transgenic mice. Proc Natl Acad Sci U S A 93:10483–10488
Zurück zum Zitat Wagoner LE, Craft LL, Singh B, Suresh DP, Zengel PW, McGuire N, Abraham WT, Chenier TC, Dorn GW II, Liggett SB (2000) Polymorphisms of the beta(2)-adrenergic receptor determine exercise capacity in patients with heart failure. Circ Res 86:834–840 Wagoner LE, Craft LL, Singh B, Suresh DP, Zengel PW, McGuire N, Abraham WT, Chenier TC, Dorn GW II, Liggett SB (2000) Polymorphisms of the beta(2)-adrenergic receptor determine exercise capacity in patients with heart failure. Circ Res 86:834–840
Zurück zum Zitat Wagoner LE, Craft LL, Zengel P, McGuire N, Rathz DA, Dorn GW II, Liggett SB (2002) Polymorphisms of the beta1-adrenergic receptor predict exercise capacity in heart failure. Am Heart J 144:840–846 Wagoner LE, Craft LL, Zengel P, McGuire N, Rathz DA, Dorn GW II, Liggett SB (2002) Polymorphisms of the beta1-adrenergic receptor predict exercise capacity in heart failure. Am Heart J 144:840–846
Zurück zum Zitat Winker R, Rüdiger H (2001) Orthostatische Intoleranz - Bedeutung in der Arbeitsmedizin. ASU 36:325–331 Winker R, Rüdiger H (2001) Orthostatische Intoleranz - Bedeutung in der Arbeitsmedizin. ASU 36:325–331
Zurück zum Zitat Winker R, Barth A, Dorner W, Mayr O, Pilger A, Ivancsits S, Ponocny I, Heider A, Wolf C, Rudiger HW (2003) Diagnostic management of orthostatic intolerance in the workplace. Int Arch Occup Environ Health 76:143–150 Winker R, Barth A, Dorner W, Mayr O, Pilger A, Ivancsits S, Ponocny I, Heider A, Wolf C, Rudiger HW (2003) Diagnostic management of orthostatic intolerance in the workplace. Int Arch Occup Environ Health 76:143–150
Metadaten
Titel
Functional adrenergic receptor polymorphisms and idiopathic orthostatic intolerance
verfasst von
R. Winker
A. Barth
E. Valic
R. Maier
W. Osterode
A. Pilger
H. W. Rüdiger
Publikationsdatum
01.04.2005
Erschienen in
International Archives of Occupational and Environmental Health / Ausgabe 3/2005
Print ISSN: 0340-0131
Elektronische ISSN: 1432-1246
DOI
https://doi.org/10.1007/s00420-005-0605-y

Weitere Artikel der Ausgabe 3/2005

International Archives of Occupational and Environmental Health 3/2005 Zur Ausgabe